David A. Siegel Celcuity Inc. Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Celcuity Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 19,700 shares of CELC stock, worth $287,226. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,700
Previous 15,200
29.61%
Holding current value
$287,226
Previous $328,000
1.83%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CELC
# of Institutions
93Shares Held
30.1MCall Options Held
4.8KPut Options Held
126K-
Bvf Inc San Francisco, CA3.47MShares$50.5 Million1.74% of portfolio
-
Morgan Stanley New York, NY2.84MShares$41.3 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.36MShares$34.4 Million1.12% of portfolio
-
Baker Bros. Advisors LP New York, NY1.87MShares$27.3 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.57MShares$22.8 Million0.0% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $218M
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...